Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17,481.37% | 15,364.27% | 12,416.16% | 2,483.31% | -84.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17,481.37% | 15,364.27% | 12,416.16% | 2,483.31% | -84.08% |
| Cost of Revenue | -86.19% | -94.44% | -95.63% | -119.04% | -80.86% |
| Gross Profit | 18,533.64% | 17,545.92% | 16,545.53% | 2,721.10% | -84.24% |
| SG&A Expenses | 24.40% | 28.95% | 81.99% | 71.44% | 74.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 757.01% | -- | 385,611.69% | 13,971.93% | 1,549.51% |
| Total Operating Expenses | 78.79% | 81.02% | 79.65% | 78.91% | 46.78% |
| Operating Income | 603.56% | 672.21% | 768.16% | 1,157.88% | -116.57% |
| Income Before Tax | 715.63% | 778.49% | 807.49% | 1,166.99% | -58.20% |
| Income Tax Expenses | 13,637.85% | 12,491.70% | 13,109.56% | 12,393.35% | 11.77% |
| Earnings from Continuing Operations | 668.93% | 728.20% | 753.48% | 1,094.85% | -58.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 668.93% | 728.20% | 753.48% | 1,094.85% | -58.66% |
| EBIT | 603.56% | 672.21% | 768.16% | 1,157.88% | -116.57% |
| EBITDA | 612.99% | 684.19% | 783.14% | 1,189.85% | -122.09% |
| EPS Basic | 650.74% | 688.72% | 682.91% | 960.04% | -37.12% |
| Normalized Basic EPS | 661.86% | 700.91% | 711.68% | 1,005.66% | -77.27% |
| EPS Diluted | 641.73% | 679.21% | 673.69% | 943.79% | -36.68% |
| Normalized Diluted EPS | 652.74% | 691.23% | 702.08% | 988.78% | -76.60% |
| Average Basic Shares Outstanding | 2.63% | 6.15% | 11.48% | 17.31% | 16.19% |
| Average Diluted Shares Outstanding | 2.99% | 6.52% | 11.87% | 16.80% | 15.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |